Overview

A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

Status:
Completed

Trial end date:
2020-02-07

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the bioequivalence of the newly formulated Tylenol tablet (acetaminophen 650 milligram [mg]) with respect to the Tylenol 8 hour (H) extended-release (ER) tablet (acetaminophen 650 mg) in healthy participants under fed conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Janssen Korea, Ltd., Korea

Treatments:

Acetaminophen